Australian guidelines released on anti-TNF therapy for IBD
17 March 2010
| by Tony James
New Australian guidelines have been released on the use of the anti-TNF agents infliximab and adalimumab to treat inflammatory bowel disease, stressing the need for a careful assessment of likely risks and benefits....
Want to read complete article? Please Sign in or Register.